© Drug Hunter Inc. 2018-2023
Home > LMB763 (nidufexor)
selective FXR partial agonist
orally efficacious in NASH models
from two 3M compound HTS and LBD
J. Med. Chem., Jan. 15, 2020
Novartis (GNF), San Diego, CA
LMB763 (nidufexor) (Novartis (GNF) oral in vivo selective FXR partial agonist)
You don’t have time to read everything, but you can’t afford to fall behind.
Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.
Get ahead now by requesting a trial.
Molecules of the Month
Molecule of the Year